10 results
Search Results
2. Neurodevelopmental outcome of nutritional intervention in newborn infants at risk of neurodevelopmental impairment: the Dolphin neonatal double-blind randomized controlled trial.
- Author
-
Andrew, Morag J., Montague‐Johnson, Christine, Laler, Karen, Baker, Bonny, Sullivan, Peter B., Parr, Jeremy R., Holmes, Jane, and Montague-Johnson, Christine
- Subjects
NEWBORN infants ,NEUROLOGICAL disorders ,DOCOSAHEXAENOIC acid ,RANDOMIZED controlled trials ,BLIND experiment ,NUCLEOTIDES ,CHOLINE ,PREMATURE infant disease prevention ,CHILD development ,COMPARATIVE studies ,DIET therapy ,PREMATURE infants ,PREMATURE infant diseases ,RESEARCH methodology ,MEDICAL cooperation ,RESEARCH ,STATISTICAL sampling ,EVALUATION research ,THERAPEUTICS - Abstract
Copyright of Developmental Medicine & Child Neurology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2018
- Full Text
- View/download PDF
3. Nutritional intervention and neurodevelopmental outcome in infants with suspected cerebral palsy: the Dolphin infant double-blind randomized controlled trial.
- Author
-
Andrew, Morag J., Montague‐Johnson, Christine, Laler, Karen, Baker, Bonny, Sullivan, Peter B., Parr, Jeremy R., Qi, Cathy, and Montague-Johnson, Christine
- Subjects
NEURODEVELOPMENTAL treatment for infants ,CEREBRAL palsy ,DOCOSAHEXAENOIC acid ,NUTRITION ,RANDOMIZED controlled trials ,CEREBRAL palsy treatment ,NUCLEOTIDES ,CHOLINE ,CHILD development ,COMPARATIVE studies ,DIET therapy ,RESEARCH methodology ,MEDICAL cooperation ,RESEARCH ,STATISTICAL sampling ,EVALUATION research ,BLIND experiment ,DISEASE complications ,PSYCHOLOGY ,THERAPEUTICS - Abstract
Copyright of Developmental Medicine & Child Neurology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2018
- Full Text
- View/download PDF
4. A health advocacy intervention for adolescents with intellectual disability: a cluster randomized controlled trial.
- Author
-
Lennox, Nicholas, McPherson, Lyn, Bain, Chris, O'Callaghan, Michael, Carrington, Suzanne, and Ware, Robert S
- Subjects
INTELLECTUAL disabilities ,HEALTH education ,HEALTH promotion ,MENTAL health of teenagers ,RANDOMIZED controlled trials ,THERAPEUTICS ,COMPARATIVE studies ,HEALTH status indicators ,RESEARCH methodology ,MEDICAL cooperation ,PEOPLE with intellectual disabilities ,HEALTH outcome assessment ,PAMPHLETS ,POCKET computers ,PREVENTIVE health services ,RESEARCH ,SCHOOL health services ,EVALUATION research - Abstract
Aim: Adolescents with intellectual disability experience poorer heath than their peers in the general population, partially due to communication barriers and knowledge gaps in their health history. This study aimed to test a health intervention package against usual care for a range of health promotion and disease detection outcomes.Method: A parallel-group cluster randomized controlled trial was conducted with Australian adolescents with intellectual disability living in the community. Randomization occurred at school level. The intervention package consisted of classroom-based health education, a hand-held personalized health record, and a health check. Evidence of health promotion, disease prevention, and case-finding activities were extracted from general practitioners' records for 12 months post-intervention.Results: Clinical data was available for 435 of 592 (73.5%) participants from 85 schools. Adolescents allocated to receive the health intervention were more likely to have their vision (odds ratio [OR] 3.3; 95% confidence interval [CI] 1.8-6.1) and hearing (OR 2.7; 95% CI 1.0-7.3) tested, their blood pressure checked (OR 2.4; 95% CI 1.6-3.7), and weight recorded (OR 4.8; 95% CI 3.1-7.6). There was no difference between health intervention and usual care for identification of new diseases.Interpretation: The school-based intervention package increased healthcare activity in adolescents with intellectual disability living in the community. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
5. Injection frequency of botulinum toxin A for spastic equinus: a randomized clinical trial.
- Author
-
Hastings‐Ison, Tandy, Blackburn, Christine, Rawicki, Barry, Fahey, Michael, Simpson, Pam, Baker, Richard, and Graham, Kerr
- Subjects
EQUINUS deformity ,BOTULINUM A toxins ,CHILDREN with cerebral palsy ,HEALTH outcome assessment ,GAIT in humans ,CLINICAL drug trials ,HEALTH ,THERAPEUTICS ,BOTULINUM toxin ,MUSCLE relaxants ,CEREBRAL palsy ,COMPARATIVE studies ,FUNCTIONAL assessment ,GAIT disorders ,LONGITUDINAL method ,RESEARCH methodology ,MEDICAL cooperation ,NEUROLOGIC examination ,NEUROLOGICAL disorders ,QUALITY of life ,RESEARCH ,EVALUATION research ,RANDOMIZED controlled trials ,BLIND experiment ,DISEASE complications ,PSYCHOLOGY - Abstract
Aim: We compared two botulinum toxin A (BoNT-A) injection frequency regimens, 12-monthly versus 4-monthly, for spastic equinus in a randomized clinical trial. The primary outcome measure was passive ankle dorsiflexion.Method: Forty-two ambulant children with spastic equinus, secondary to cerebral palsy (23 males and 19 females; mean age 3y 6mo, SD 13mo; GMFCS levels I [n=20], II [n=19], III [n=3]) were randomized to receive either 12-monthly or 4-monthly BoNT-A injections to the calf, over a 26-month period. Twenty-one children had spastic hemiplegia, 21 children had spastic diplegia. A fixed 6U/kg dose of Botox was injected into the gastrocnemius muscle of both limbs in children with diplegia and the gastrocsoleus of the affected limb in children with hemiplegia, under mask anaesthesia.Results: Forty-two children entered the trial with 21 participants randomized to each group. There were three withdrawals and two children received serial casting midway through the trial. There was no significant difference in passive dorsiflexion between 12-monthly and 4-monthly regimens (p=0.41). There were also no significant between group differences on secondary outcome measures. There were no serious adverse events - the rate was 1.2 adverse events per child per year in the 12-monthly group and 2.2 adverse events per child per year in the 4-monthly group. Subgroup analysis revealed a significant difference in passive dorsiflexion between children with hemiplegia and diplegia (p=0.01).Interpretation: There was no significant difference between 12-monthly and 4-monthly injection regimens on passive dorsiflexion or secondary outcome measures. BoNT-A injections for spastic equinus may be recommended on a 12-monthly basis. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
6. Teaching reading to children with neurofibromatosis type 1: a clinical trial with random assignment to different approaches.
- Author
-
Barquero, Laura A, Sefcik, Angela M, Cutting, Laurie E, and Rimrodt, Sheryl L
- Subjects
NEUROFIBROMATOSIS 1 ,NEUROFIBROMATOSIS in children ,REMEDIAL reading teaching ,CLINICAL trials ,VISUAL perception ,KINESTHETIC method (Education) ,COMPARATIVE studies ,DYSLEXIA ,RESEARCH methodology ,MEDICAL cooperation ,READING ,RESEARCH ,RESEARCH funding ,SPECIAL education ,EVALUATION research ,RANDOMIZED controlled trials ,TREATMENT effectiveness ,DISEASE complications ,THERAPEUTICS - Abstract
Aim: Neurofibromatosis type 1 (NF1) is a genetic disorder with a cognitive profile that includes visual-spatial perception deficits and a high incidence of reading disability. There is a paucity of information about how this cognitively complex population responds to mainstream reading interventions. The clinical trial goals were to determine whether children and adolescents with NF1 and reading deficits (NF+RD) benefit from mainstream remedial reading programs and whether responsiveness varies with differences in program-related visual-spatial demands.Method: Forty-nine participants (28 males, 21 females; aged 8-14y) with either NF+RD (n=17, 11 males, six females) or idiopathic reading deficit (IRD) (n=32, 17 males, 15 females) were randomly assigned to intensive remedial teaching using one of two multisensory reading programs: one with greater kinesthetic demands and the other with greater visual-spatial demands. Two control groups - wait-list IRD (n=14, 11 males, three females) and typically developing readers (n=26, 13 males, 13 females) - received no treatment. Repeated measures and multivariate ANOVA analyses compared each group's growth in reading achievement from pre- to post-testing.Results: Treated groups showed significant growth whereas untreated groups did not. Comparing treated groups, the IRD group responded equally well to both interventions, whereas the NF+RD group showed a better response to the more kinesthetic approach.Interpretation: Results suggest that multisensory remedial reading teaching that emphasizes kinesthetic demands more than visual-spatial demands is suitable for students with NF+RD. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF
7. Botulinum toxin A injections and occupational therapy in children with unilateral spastic cerebral palsy: a randomized controlled trial.
- Author
-
Lidman, Git, Nachemson, Ann, Peny‐Dahlstrand, Marie, and Himmelmann, Kate
- Subjects
CHILDREN with cerebral palsy ,BOTULINUM toxin ,THERAPEUTICS ,RANDOMIZED controlled trials ,OCCUPATIONAL therapy ,HEALTH outcome assessment - Abstract
Aim To investigate the effects of repeated botulinum toxin A (Bo NT-A) injections combined with occupational therapy, including a splint, compared with occupational therapy alone on hand function in children with unilateral spastic cerebral palsy ( USCP), in all International Classification of Functioning, Disability and Health ( ICF) domains. Method This was a randomized controlled study, population-based and evaluator-blinded for primary outcome (October 2004 to September 2010). Twenty children (14 males; median age 3y 1mo) with USCP, recruited at a rehabilitation centre in Sweden, were assigned to one of two parallel groups using concealed allocation. In the course of one year, 10 children received occupational therapy, while 10 received repeated Bo NT-A plus occupational therapy (Bo NT-A/ OT). Primary outcome (Assisting Hand Assessment [ AHA]), and secondary outcome measures (range of movement [ ROM], and Canadian Occupational Performance Measure), were measured at baseline, 3, 6, 9, and 12 months. Results AHA revealed a superior effect in the Bo NT-A/ OT group at 12 months: 6 out of 10 improved compared with 1 out of 10 in the occupational therapy group ( p<0.03). A 95% Peskun exact confidence interval for the difference in proportions is given as 0.01 to 0.81. Secondary outcomes improved in both groups. Interpretation Repeated Bo NT-A/ OT appeared superior to occupational therapy alone for bimanual performance in young children with USCP. Active ROM and goal performance improved in both groups. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
8. Non-pharmacological management of problematic sleeping in children with developmental disabilities.
- Author
-
Spruyt, Karen and Curfs, Leopold M G
- Subjects
SLEEP disorders in children ,CHILDREN with developmental disabilities ,NEUROPLASTICITY ,SLEEP-wake cycle ,RANDOMIZED controlled trials ,THERAPEUTICS - Abstract
Aim Sleep is important for underlying neural plasticity, and children with developmental disabilities suffer behavioural, emotional, cognitive, and sensory-motor issues that affect their wake and sleep states. Problematic sleeping can be hypothesized to have adverse effects on both of these areas in children with developmental disabilities. With this review, we aim to provide a benchmark in managing problematic sleeping in children with developmental disabilities. Method A literature search was conducted and data on the study descriptives, patient characteristics, study design, study-related factors, criteria applied to operationalize sleep and developmental disability, and sleep 'management' were collected. Each management strategy was tabulated and analysed. Results We identified 90 studies involving 1460 children with developmental disabilities, of whom 61.6% were male. The highest proportion of studies, almost half, were in children with syndromes (44.4%), followed by studies in children with intellectual disabilities (18.9%). Non-pharmacological sleep management was primarily aimed at improving sleep quality (86.7%), followed by sleep-wake schedules and, to a certain extent, sleep regularity (42.2%). About 56.7% of the studies reported more than one approach. Studies mostly focused on disorders of initiating and maintaining sleep through a diversity of strategies and relied heavily on subjective measures to identify and monitor problematic sleeping. Sleep management approaches were primarily delivered at the level of the individual in the home setting. The number of management approaches per study was unrelated to the number of sleep problems discussed. Interpretation Modifying sleep management strategies to meet the specific needs of children with developmental disabilities is encouraged, and studies that look beyond sleep quality or sleep quantity are required. It is also advocated that modifications to sleep hygiene, sleep regularity, and sleep ecology in a population with developmental disabilities are rigorously investigated. Finally, daytime somnolence should not be overlooked when aiming to optimize sleep in children with developmental disabilities across the ages and stages of their lives. There were several limitations in the research findings of problematic sleep in children with developmental disabilities. In general, the sleep problems and the developmental disabilities investigated were multicomponent in nature. It is likely that management approaches impacted those problems on multiple levels or through diverse 'therapeutic' pathways. There is a need for randomized controlled trials and more objective measures that quantify improved sleep or wake states. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
9. Intensive therapy following upper limb botulinum toxin A injection in young children with unilateral cerebral palsy: a randomized trial.
- Author
-
Hoare, Brian, Imms, Christine, Villanueva, Elmer, Rawicki, Hyam Barry, Matyas, Thomas, and Carey, Leeanne
- Subjects
CHILDREN with cerebral palsy ,CRITICAL care medicine ,ARM diseases ,BOTULINUM toxin ,THERAPEUTICS ,RANDOMIZED controlled trials ,TREATMENT effectiveness ,CONSTRAINT-induced movement therapy - Abstract
Aim Botulinum toxin A (BoNT-A) combined with occupational therapy is effective in improving upper limb outcomes in children with unilateral cerebral palsy (CP). It is now essential to identify the most effective therapies following BoNT-A. Given the added burden for children and families, the aim of this study was to explore whether modified constraint-induced movement therapy ( mCIMT) leads to sufficiently superior gains compared with bimanual occupational therapy (BOT) in young children with unilateral CP following BoNT-A injections. Method In this randomized, controlled, evaluator-blinded trial, 34 children (20 males, 14 females; mean age 3y, SD 1y 4mo, range 18mo-6y) with unilateral CP were randomized using concealed allocation to one of two 8-week interventions. The experimental group ( n=17) received BoNT-A and mCIMT. The comparison group ( n=17) received BoNT-A and BOT. Participants were recruited from a physical rehabilitation clinic and randomized between August 2003 and May 2009. Primary outcome was measured using the Assisting Hand Assessment at 3 months. Secondary outcomes were measured at 3 months and 6 months using the Quality of Upper Extremity Skills Test, the Pediatric Evaluation of Disability Inventory, Canadian Occupational Performance Measure, and the Goal Attainment Scale. Results There were no clinically important differences between groups at baseline. Immediately following intervention, there was no evidence of a superior effect for BoNT-A + mCIMT as determined by the Assisting Hand Assessment (estimated mean difference [EMD] 0.81, upper 95% confidence limit 3.6; p=0.32) or secondary outcomes. However, both groups showed improvement over time (BoNT-A + mCIMT: EMD 2.7, 95% confidence interval [CI] 0.7-5.2; BONT-A + BOT: EMD 4.7, 95% CI 2.1-8.6). Follow-up at 6 months also demonstrated no superior effect for BoNT-A + mCIMT. Interpretation Following upper limb injection of BoNT-A, there was no evidence that mCIMT, despite the significantly increased intensity of the home programme, produced a superior effect across a range of outcomes compared with a structured programme of BOT in young children with unilateral CP. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
10. Improving upper limb motor functions through action observation treatment: a pilot study in children with cerebral palsy.
- Author
-
BUCCINO, GIOVANNI, ARISI, DANIELE, GOUGH, PATRICIA, APRILE, DANIELA, FERRI, CHIARA, SEROTTI, LUCIA, TIBERTI, ALESSANDRA, and FAZZI, ELISA
- Subjects
MOVEMENT disorders in children ,ARM physiology ,RANDOMIZED controlled trials ,CHILDREN with cerebral palsy ,MOTOR ability in children ,HEMIPLEGIA ,QUADRIPLEGIA ,PSYCHOPHYSIOLOGY ,THERAPEUTICS - Abstract
Aim The aim of this randomized controlled trial was to assess whether action observation treatment may improve upper limb motor functions in children with cerebral palsy (CP). Method All children with CP admitted to our unit for rehabilitation from May 2009 to May 2010 were eligible. Inclusion criteria were age between 6 years and 11 years, an IQ of at least 70, and no major visual and/or auditory deficits. Fifteen children were enrolled and randomly assigned to either a case group ( n=8; four males, four females; median age 7y 6mo) or control group ( n=7; five males, two females; median age 8y). Six participants had left-sided hemiplegia, six right-sided hemiplegia, and three had tetraplegia; 10 were independent walkers. Those in the case group were asked to observe video clips showing daily age-appropriate actions, and afterwards to imitate them. Participants in the control group were asked to observe video clips with no motor content and afterwards to execute the same actions as cases. The primary outcome measure was the Melbourne Assessment Scale. Children were scored twice at baseline (2wks apart), and at the end of treatment, by a physician blind to group assignment. Results At baseline groups did not differ on functional evaluation. After treatment, the functional score gain (Δ) was significantly different in the case and control groups ( p=0.026). Interpretation The present results support the notion that action observation treatment can be an effective part of the rehabilitation programme in children with CP. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.